(Press-News.org) Reston, VA (September 17, 2025)—A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy significantly reduced cancer activity and provided symptom relief, underscoring its potential as a viable treatment option. This research was published in the September issue of The Journal of Nuclear Medicine.
SFT is a rare type of soft tissue tumor with few treatment options available. Although most SFTs are classified as benign with minimal risk of recurrence, about 15 to 20 percent are malignant, and those considered benign have the potential for malignant transformation. For patients with malignant disease, treatment options are scarce, and outcomes are often poor.
"In several sarcomas, particularly SFT, fibroblast activation protein (FAP) is highly expressed on the surface of tumor cells and surrounding fibroblasts," said Helena Lanzafame, MD, researcher in the Department of Nuclear Medicine at University Hospital Essen in Essen, Germany. "We sought to deliver radiation therapy directly to the FAP target with the novel radioligand therapy, 90Y-FAPI-46."
The study included three patients who had already tried multiple standard therapies without success. Molecular analysis of their tumor tissues revealed remarkably high levels of the FAP protein, confirmed with advanced FAPI-46 PET imaging. Patients received four cycles of 90Y-FAPI-46 therapy and their treatment response was evaluated with 18F-FDG and 68Ga-FAPI-46 PET/CT.
Imaging revealed that all patients experienced tumor shrinkage or disease stabilization, as well as significant relief from symptoms, such as severe fatigue and abdominal pain. In addition, no serious side effects were observed among the patients.
"This is the first time we have seen such strong and deep responses in advanced SFT using this precision radiation approach," noted Rainer Hamacher, MD, lead oncologist in the Department of Medical Oncology, Sarcoma Center, West German Cancer Center at University Hospital Essen. "Our findings suggest that screening for FAP expression could help identify patients most likely to benefit from this novel therapy."
The team emphasizes that these are early results from a small number of carefully selected patients. Larger prospective clinical trials are needed to confirm the therapy s safety and effectiveness, and to understand how best to integrate it into existing treatment strategies.
The authors of 90Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors include Helena Lanzafame, Kim Magaly Pabst, Pedro Fragoso Costa, Michael Nader, Stephan Leyser, and Wolfgang Peter Fendler, Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany, and German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany; Christoph E. Heilig, Simon Kreutzfeldt, and Stefan Fr hling, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany, National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany, and German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Eva Wardelmann and Sebastian M hl, Gerhard-Domagk-Institute of Pathology, University of M nster, M nster, Germany; M lanie Desaulniers, Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany, German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany, and Department of Nuclear Medicine and Radiobiology, Universit de Sherbrooke, Sherbrooke, Quebec, Canada; Ilektra Antonia Mavroeidi, Ina Pretzell, and Rainer Hamacher, German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany, and Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; Martin Schuler and Sebastian Bauer, German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany, Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany, and National Center for Tumor Diseases West, Essen, Germany; Jens Thomas Siveke, German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany, Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany, Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany, Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany, and German Cancer Research Center, Heidelberg, Germany; Leila Kamkar, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany, and National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany; and Ken Herrmann, Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany, German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany, and National Center for Tumor Diseases West, Essen, Germany.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
New targeted radiation therapy shows near-complete response in rare sarcoma patients
2025-09-17
ELSE PRESS RELEASES FROM THIS DATE:
Does physical frailty contribute to dementia?
2025-09-17
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, SEPTEMBER 17, 2025
MINNEAPOLIS — A new study suggests that physical frailty may contribute to the development of dementia. The study was published on September 17, 2025, in Neurology®, the medical journal of the American Academy of Neurology.
Physical frailty is defined as having three or more of these five symptoms: often feeling tired; little or no physical activity; slow walking speed; low grip strength; and unintentional weight loss.
“We’ve known that frailty is associated with a higher risk of ...
Soccer headers and brain health: Study finds changes within folds of the brain
2025-09-17
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, SEPTEMBER 17, 2025
MINNEAPOLIS — In amateur soccer players, more frequent heading, or using the head to control or pass the ball, is linked to alterations within the folds of the brain, according to a study published on September 17, 2025, in Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that soccer heading causes brain changes, it only shows an association.
“While taking part in sports has many benefits, including possibly reducing ...
Decoding plants’ language of light
2025-09-17
Researchers have revealed a previously unknown way plants shape their growth in response to light — a breakthrough that could better equip crops to handle environmental stress.
In a first-of-its-kind finding, the team discovered how a compound that’s involved in plant metabolism can actually "reprogram” an unrelated light-sensing protein.
This unexpected interaction, which was reported in the journal Nature Communications, is an exciting step toward more fully understanding plant physiology.
“In the future, this mechanism could be exploited to fine-tune plant growth, development and stress ...
UNC Greensboro study finds ticks carrying Lyme disease moving into western NC
2025-09-17
GREENSBORO, NC (xx/xx/2025) - North Carolina is experiencing a surge in Lyme disease cases, and a new surveillance study from UNC Greensboro (UNCG) reveals that the primary vector of the bacteria that cause Lyme disease, the blacklegged tick (Ixodes scapularis), has been spreading into areas previously considered low risk.
“Currently, 16 states, mostly in the Northeast, mid-Atlantic, and upper Midwest, account for 95% of the reported LD cases,” says Dr. Gideon Wasserberg, a biology professor ...
New implant restores blood pressure balance after spinal cord injury
2025-09-17
Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs.
In 2022 Krebs experienced a severe spinal cord injury (SCI) in a motor vehicle accident. Since that time, Krebs requires the use of a wheelchair. The damage to his spinal cord means his brain can no longer control blood pressure in his body. He was vulnerable to blood pressure drops where he was at risk of losing consciousness, and spikes placing him at risk of a heart attack and stroke. However, an international clinical trial led by teams at the University of Calgary, École Polytechnique Fédérale de Lausanne (EPFL), and University ...
New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows
2025-09-17
New York City offers nearly every type of medical specialist but provides fewer specialty healthcare providers per capita than smaller cities, according to a new study that challenges conventional assumptions about urban healthcare advantages and reveals a troubling paradox across America's largest metropolitan areas.
The research, published in Nature Cities, analyzed data from 1.4 million healthcare providers across 75 medical specialties in 898 metropolitan and micropolitan areas. The innovative approach combines urban scaling theory—which ...
Could a local anesthetic that doesn’t impair motor function be within reach?
2025-09-17
All current local anesthetics block sensory signals — pain — but they also interrupt motor signals, which can be problematic. For example, too much epidural anesthesia can prevent mothers in labor from being able to push. Prolonged local anesthesia after orthopedic surgery can leave patients unable to participate in rehab.
Researchers at Boston Children’s Hospital now report an alternative local anesthetic, 2',6'-pipecolylxylidine (PPX), in the journal Anesthesiology, the peer-reviewed ...
1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5
2025-09-17
1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5,000 strandings
Article URL: http://plos.io/47pWwAl
Article title: Assessing fishery interaction on cetaceans stranded along the Italian coastline between 1986 and 2023
Author countries: Italy
Funding: The author(s) received no specific funding for this work. END ...
In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day
2025-09-17
The first-ever measurements of the ethanol content of fruits available to chimpanzees in their native African habitat show that the animals could easily consume the equivalent of more than two standard alcoholic drinks each day, according to researchers at the University of California, Berkeley.
It's not clear whether they actively seek out fruit with high ethanol levels, which are typically riper fruit with more sugars to ferment. But the availability of ethanol in many species of fruit that they normally eat suggests that alcohol is a regular part of their diet and likely was a part of the diets of our human ancestors.
"Across all sites, male and female chimpanzees ...
Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds
2025-09-17
Permafrost, ground frozen for at least two years underlying the cold Arctic and alpine regions of the Northern Hemisphere, covers about 17% of the global land surface and stores an estimated one-third of the world's soil organic carbon. As climate change causes this permafrost to thaw, the potential release of greenhouse gases (GHGs) has raised concerns about passing a tipping point, triggering an irreversible positive feedback loop that accelerates warming. A critical unanswered question has been whether these ecosystems can ...